INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 1 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,041 | -12.9% | 30,953 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,821 | -45.5% | 30,953 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $25,381 | -47.4% | 30,953 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $48,287 | -8.9% | 30,953 | 0.0% | 0.01% | -22.2% |
| Q3 2022 | $53,000 | -1.9% | 30,953 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $54,000 | -51.4% | 30,953 | 0.0% | 0.01% | -46.7% |
| Q1 2022 | $111,000 | -27.0% | 30,953 | +1.3% | 0.02% | -25.0% |
| Q4 2021 | $152,000 | -30.9% | 30,548 | -1.0% | 0.02% | -33.3% |
| Q3 2021 | $220,000 | -23.1% | 30,842 | 0.0% | 0.03% | -23.1% |
| Q2 2021 | $286,000 | +1.4% | 30,842 | +1.4% | 0.04% | -7.1% |
| Q1 2021 | $282,000 | +9.7% | 30,402 | +4.6% | 0.04% | -4.5% |
| Q4 2020 | $257,000 | – | 29,076 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |